寿仙谷

603896.SH

Wind Industry: 医疗保健 > 医药生物 > 制药 > 中药

公司始建于1909年，是一家集名贵中药材良种选育、研究、栽培、生产、营销为一体的中华老字号企业、国家高新技术企业、国家重点农业龙头企业，“武义寿仙谷中药炮制技艺”被国务院列入“国家级非物质文化遗产代表性项目名录”。公司于2017年在上海证券交易所主板上市。公司秉承“重德觅上药、诚善济世人”的祖训，恪守“为民众的健康美丽长寿服务”的企业宗旨，致力于打造“有机国药第一品牌”、“世界灵芝领导品牌”。公司先后承担国家及省部级科技专项，以自主选育优良新品种、五重有机认证、多项制定并发布实施的国际、国家及行业等标准、多项专利，多项国家、省部科技奖，引领产业高质量发展，获国际标准制定重大贡献奖、浙江省标准创新优秀贡献奖、浙江省人民政府质量奖，2024年获“国家科学技术进步一等奖”。公司主营去壁灵芝孢子粉、铁皮石斛和藏红花三大系列产品。系列产品获评“浙产名药”、浙江制造“品字标”，全国十大灵芝品牌、“中国好石斛”。

ESG Score Industry Ranking:
5 / 282 (制药)

ESG Rating Distribution(制药)

0.35%

AAA

2.84%

17.73%

20.21%

BBB

30.14%

24.11%

0.35%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.18Updated on 2026-10-29

08.1810

Management & Practices Score：5.18Updated on 2026-09-16

05.187

Controversies Score：3.00Updated on 2026-10-29

03.003

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	6.54	3.56	22.85%
Social	7.51	3.72	49.76%
Governance	7.92	5.34	27.39%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(282 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	600535.SH	天士力	AAA	8.94	3.00	5.94	9.07	8.63	7.75
2	301130.SZ	西点药业	AA	8.39	3.00	5.39	7.28	7.78	7.92
3	3320.HK	华润医药	AA	8.31	3.00	5.31	7.23	7.73	7.62
4	600380.SH	健康元	AA	8.22	3.00	5.22	5.64	8.16	7.66
5	603896.SH	寿仙谷	AA	8.18	3.00	5.18	6.54	7.51	7.92
6	600329.SH	达仁堂	AA	8.15	3.00	5.15	6.24	7.44	8.16
7	601607.SH	上海医药	AA	8.07	3.00	5.07	7.19	7.17	7.40
8	000999.SZ	华润三九	AA	8.03	3.00	5.03	7.66	7.39	6.42
9	301281.SZ	科源制药	A	7.99	2.99	4.99	5.58	7.51	7.72
10	000513.SZ	丽珠集团	AA	7.94	2.99	4.94	5.51	7.94	6.76